Ranbaxy is a large pharmaceutical company based in India with global reach. It has a presence in many developed and emerging markets. It has strengths in generics with a large ANDA pipeline and capabilities in branded generics. It also has partnerships for new drug discovery. Recent strategic alliances will help strengthen its business model and drive future growth across markets.
10. $ Million Extensive ground presence, especially in high-growth brand-driven emerging markets * 2009 Guidance is based on INR-USD exchange rate of 50.5
19. Pharma & Business Imperatives… With increasing pressures in the developed world, high-growth emerging markets necessitate higher focus
20. … Are Forcing a Rethink of Established Models Going forward, will “pure-play” models be able to cater to shareholder expectations? Generic Companies